Bimodal Fucoidan-Coated Zinc Oxide/Iron Oxide-Based Nanoparticles for the Imaging of Atherothrombosis.
MRI
atherothrombosis
contrast agents
fucoidan
iron oxide
nanoparticles
optical imaging
zinc oxide
Journal
Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009
Informations de publication
Date de publication:
08 Mar 2019
08 Mar 2019
Historique:
received:
02
02
2019
revised:
03
03
2019
accepted:
06
03
2019
entrez:
13
3
2019
pubmed:
13
3
2019
medline:
21
6
2019
Statut:
epublish
Résumé
A polyol method was used to obtain ultrasmall ZnO nanoparticles (NPs) doped with iron ions and coated with a low molecular weight fucoidan in order to perform in vivo MR and ex vivo fluorescence imaging of athrothrombosis. During the synthesis, the early elimination of water by azeotropic distillation with toluene allowed us to produce NPs which size, determined by XRD and TEM, decreased from 7 nm to 4 nm with the increase of iron/zinc ratios from 0.05 to 0.50 respectively. For the highest iron content (NP-0.50) NPs were evidenced as a mixture of nanocrystals made of wurtzite and cubic phase with a molar ratio of 2.57:1, although it was not possible to distinguish one from the other by TEM. NP-0.50 were superparamagnetic and exhibited a large emission spectrum at 470 nm when excited at 370 nm. After surface functionalization of NP-0.50 with fucoidan (fuco-0.50), the hydrodynamic size in the physiological medium was 162.0 ± 0.4 nm, with a corresponding negative zeta potential of -48.7 ± 0.4 mV, respectively. The coating was evidenced by FT-IR spectra and thermogravimetric analysis. Aqueous suspensions of fuco-0.50 revealed high transverse proton relaxivities (T₂) with an r₂ value of 173.5 mM
Identifiants
pubmed: 30857260
pii: molecules24050962
doi: 10.3390/molecules24050962
pmc: PMC6429451
pii:
doi:
Substances chimiques
Contrast Media
0
Ferric Compounds
0
Polysaccharides
0
ferric oxide
1K09F3G675
fucoidan
9072-19-9
Zinc Oxide
SOI2LOH54Z
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
Mar Drugs. 2014 Sep 23;12(9):4851-67
pubmed: 25251032
J Mater Chem B. 2017 Apr 28;5(16):2896-2907
pubmed: 32263983
Spectrochim Acta A Mol Biomol Spectrosc. 2013 Apr;106:247-52
pubmed: 23399911
J Nucl Med. 2011 Sep;52(9):1433-40
pubmed: 21849401
Chem Rev. 2008 Jun;108(6):2064-110
pubmed: 18543879
Adv Mater. 2013 Oct 4;25(37):5329-35
pubmed: 24089351
J Biomed Opt. 2017 Jul 1;22(7):76004
pubmed: 28697231
Circulation. 1995 Sep 1;92(5):1355-74
pubmed: 7648691
MAGMA. 2012 Jun;25(3):233-44
pubmed: 22042538
ACS Nano. 2011 Feb 22;5(2):1223-35
pubmed: 21250651
J Phys Chem B. 2014 Feb 13;118(6):1535-44
pubmed: 24467641
Adv Healthc Mater. 2017 Feb;6(4):
pubmed: 27943662
J Am Chem Soc. 2011 Aug 17;133(32):12624-31
pubmed: 21744804
Nanoscale. 2014 Mar 7;6(5):2953-63
pubmed: 24480995
Langmuir. 2013 Jul 16;29(28):8997-9003
pubmed: 23786379
Biochim Biophys Acta. 2009 Feb;1790(2):141-6
pubmed: 19026722
Int J Cardiol. 2013 Sep 30;168(2):934-45
pubmed: 23218570
Sci Rep. 2017 Dec;7(1):85
pubmed: 28273899
Materials (Basel). 2011 Jun 17;4(6):1132-1143
pubmed: 28879971
Physiol Rev. 1999 Jan;79(1):181-213
pubmed: 9922371
Mater Lett. 2016 Feb 1;162:60-63
pubmed: 26549918
J Mater Chem B. 2013 Jun 21;1(23):2985-2992
pubmed: 32260866
Ann Biomed Eng. 2006 Jan;34(1):23-38
pubmed: 16496086
PLoS One. 2015 Jul 30;10(7):e0133921
pubmed: 26226146
Nano Lett. 2009 Dec;9(12):4434-40
pubmed: 19799448
Phys Chem Chem Phys. 2011 Jun 7;13(21):10020-7
pubmed: 21409252
Nanomedicine (Lond). 2015 Jan;10(1):73-87
pubmed: 24960075
Biomacromolecules. 2014 Jun 9;15(6):2146-56
pubmed: 24785001